Prospettive Sociali e Sanitarie
Prospettive Sociali e Sanitarie
Prospettive Sociali e Sanitarie
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Kenneth Wells, Cathy Sherbourne, Naihua Duan, Jürgen Unützer, Jeanne Miranda, Michael Schoenbaum, Susan L.<br />
Ettner, Lisa S. Meredith, and Lisa Rubenstein<br />
Quality Improvement for Depression in Primary Care: Do Patients With Subthreshold Depression Benefit in the Long<br />
Run? 1149-1157<br />
Jesse H. Wright, Andrew S. Wright, Anne Marie Albano, Monica R. Basco, L. Jane Goldsmith, Troy Raffield, and<br />
Michael W. Otto<br />
Computer-Assisted Cognitive Therapy for Depression: Maintaining Efficacy While Reducing Therapist Time 1158-<br />
1164<br />
Victor L. Serebruany, Raymond F. Suckow, Thomas B. Cooper, Christopher M. O’Connor, Alex I. Malinin, K. Ranga<br />
R. Krishnan, Louis T. van Zyl, Vladimir Lekht, Alexander H. Glassman, and Sertraline Antidepressant Heart Attack<br />
Randomized Trial<br />
Relationship Between Release of Platelet/Endothelial Biomarkers and Plasma Levels of Sertraline and N-<br />
Desmethylsertraline in Acute Coronary Syndrome Patients Receiving SSRI Treatment for Depression 1165-1170<br />
Mark Hyman Rapaport, Cathryn Clary, Rana Fayyad, and Jean Endicott<br />
Quality-of-Life Impairment in Depressive and Anxiety Disorders 1171-1178<br />
Steven E. Bruce, Kimberly A. Yonkers, Michael W. Otto, Jane L. Eisen, Risa B. Weisberg, Maria Pagano, M. Tracie<br />
Shea, and Martin B. Keller<br />
Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and<br />
Panic Disorder: A 12-Year Prospective Study 1179-1187<br />
Arieh Y. Shalev and Sara Freedman<br />
PTSD Following Terrorist Attacks: A Prospective Evaluation 1188-1191<br />
Michael G. Griffin, Patricia A. Resick, and Rachel Yehuda<br />
Enhanced Cortisol Suppression Following Dexamethasone Administration in Domestic Violence Survivors 1192-1199<br />
Brief Reports:<br />
Nutan Kolluri, Zhuoxin Sun, Allan R. Sampson, and David A. Lewis<br />
Lamina-Specific Reductions in Dendritic Spine Density in the Prefrontal Cortex of Subjects With Schizophrenia 1200-<br />
1202<br />
Zafiris J. Daskalakis, Bruce K. Christensen, Paul B. Fitzgerald, Sarah I. Fountain, and Robert Chen<br />
Reduced Cerebellar Inhibition in Schizophrenia: A Preliminary Study 1203-1205<br />
Stephan Krieger, Stefanie Lis, Turan Cetin, Bernd Gallhofer, and Andreas Meyer-Lindenberg<br />
Executive Function and Cognitive Subprocesses in First-Episode, Drug-Naive Schizophrenia: An Analysis of N-Back<br />
Performance 1206-1208<br />
David J. Moser, Rebecca L. Reese, Susan K. Schultz, Michelle L. Benjamin, Stephan Arndt, Frank W. Fleming, and<br />
Nancy C. Andreasen<br />
Informed Consent in Medication-Free Schizophrenia Research 1209-1211<br />
Lori Altshuler, Susan Bookheimer, Manuel A. Proenza, Jennifer Townsend, Fred Sabb, Ann Firestine, George<br />
Bartzokis, Jim Mintz, John Mazziotta, and Mark S. Cohen<br />
Increased Amygdala Activation During Mania: A Functional Magnetic Resonance Imaging Study 1211-1213<br />
Rebecca Tillman and Barbara Geller<br />
A Brief Screening Tool for a Prepubertal and Early Adolescent Bipolar Disorder Phenotype 1214-1216<br />
David Straker, Christoph U. Correll, Elisse Kramer-Ginsberg, Nasreen Abdulhamid, Fiju Koshy, Elayna Rubens,<br />
Robert Saint-Vil, John M. Kane, and Peter Manu<br />
Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic<br />
Medications 1217-1221<br />
Joaquim Soler, Juan Carlos Pascual, Josefa Campins, Judith Barrachina, Dolors Puigdemont, Enrique Alvarez, and<br />
Victor Pérez
Change language